Nuffield Council on Bioethics
Harkness Project Title:Purchaser’s Strategies for Considering Comparative Effectiveness Data in Relation to Coverage Decisions and Value Based Insurance Design – An Exploratory Study
Co-Mentors: Norman Daniels, Ph.D.; Michael E. Chernew, Ph.D. (Harvard Medical School)
Placement: Harvard School of Public Health
Biography at time of Harkness Fellowship: Harald Schmidt, a 2009–10 Commonwealth Fund Harkness Fellow in Health Care Policy and Practice, is assistant director on the Nuffield Council on Bioethics, where he has worked since 2002. His duties include writing reports, managing working parties and other projects, and representing the council nationally and internationally. His work has focused on quality and efficiency of health care, equity, and access to care in the fields of public health, health care-related research in developing countries, pharmacogenetics, and, currently, personalized health care. Schmidt is also a research associate at LSE (London School of Economics) Health and has published on issues around personal responsibility for health in journals including the British Medical Journal, the Journal of Medical Ethics, and Health Economics, Policy and Law. He previously held a research position at the Centre for Bioethics, University of Münster, and worked at the interface of politics and academic ethics in bioethics units in the German Parliament, the German Ministry of Health, and the European Parliament. He received an M.A. in philosophy in 2001 from the University of Münster and began working towards a Ph.D. at the London School of Economics and Political Science in 2007.
Project: Harold Schmidt aimed to shed light on purchaser’s priorities in considering effectiveness data in making coverage decisions, particularly in the context of value-based insurance design initiatives. His research entailed a systematic literature review to condense the arguments for and against effectiveness-related co-payments, followed by semi-structured interviews with senior policy makers and officials from public and private plans.
Current Positions: (updated 7/2013)
Assistant Professor of Medical Ethics & Health Policy, University of Pennsylvania
- Research Associate, Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania
Schmidt H. “The Ethics of Incentivizing Mammography Screening.” JAMA. 2015.
Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, Landon BE, Zezza MA, Schmidt H, Elshaug A, “Setting a research agenda for medical overuse.” BMJ. 2015
Kreis J, Schmidt H. “Public Engagement in Health Technology Assessment and Coverage Decisions: A Study of Experiences in France, Germany, and the United Kingdom.” Journal of Health Politics, Policy and Law. 2012.
Schmidt H, Stock S, and Doran T, "Moving Forward with Wellness Incentives Under the Affordable Care Act: Lessons from Germany." The Commonwealth Fund, May 2012.
Callier SL and Schmidt H. “Managing Patient Expectations about Deidentification.” American Journal of Bioethics. 2010.
Stock S, Schmidt H, Buscher G, Gerber A et al. "Financial incentives in the Germany Statutory Health Insurance: New findings, new questions.” Health Policy 2010,
Voigt K and Schmidt H. “Wellness Programs: A Threat to Fairness and Affordable Care.” Health Care Cost Monitor. The Hastings Center. 2010.
Schmidt H, Gerber A, Stock S. “What can we learn from German health incentive schemes?” BMJ. 2008.
Schmidt H, Voigt K, Wikler D. “Carrots, Sticks, and Health Care Reform—Problems with Wellness Incentives.” NEJM Perspective. 2010.